242 related articles for article (PubMed ID: 23389250)
1. Expression and functional characterisation of natural R147W and K150del variants of protein C in the Chinese population.
Ding Q; Yang L; Hassanian SM; Rezaie AR
Thromb Haemost; 2013 Apr; 109(4):614-24. PubMed ID: 23389250
[TBL] [Abstract][Full Text] [Related]
2. Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function.
Chen C; Yang L; Villoutreix BO; Wang X; Ding Q; Rezaie AR
Thromb Haemost; 2017 Jun; 117(7):1358-1369. PubMed ID: 28405673
[TBL] [Abstract][Full Text] [Related]
3. PROC c.574_576del polymorphism: a common genetic risk factor for venous thrombosis in the Chinese population.
Tang L; Lu X; Yu JM; Wang QY; Yang R; Guo T; Mei H; Hu Y
J Thromb Haemost; 2012 Oct; 10(10):2019-26. PubMed ID: 22817391
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the protein C anticoagulant and antiinflammatory pathways.
Rezaie AR
Curr Med Chem; 2010; 17(19):2059-69. PubMed ID: 20423310
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of activated protein C functions by elimination of protein S cofactor enhancement.
Harmon S; Preston RJ; Ni Ainle F; Johnson JA; Cunningham MS; Smith OP; White B; O'Donnell JS
J Biol Chem; 2008 Nov; 283(45):30531-9. PubMed ID: 18779332
[TBL] [Abstract][Full Text] [Related]
6. Identification of a specific exosite on activated protein C for interaction with protease-activated receptor 1.
Yang L; Bae JS; Manithody C; Rezaie AR
J Biol Chem; 2007 Aug; 282(35):25493-500. PubMed ID: 17580306
[TBL] [Abstract][Full Text] [Related]
7. Ser252Asn Mutation Introduces a New N-Linked Glycosylation Site and Causes Type IIb Protein C Deficiency.
Zhou S; Wu X; Song Y; Li L; Shi C; Lai Z; Ding Q; Wu W; Dai J; Wang X; Lu Y
Thromb Haemost; 2024 May; 124(5):459-470. PubMed ID: 38011863
[TBL] [Abstract][Full Text] [Related]
8. Hereditary basis of protein C deficiency (PCD) in thrombosis patients: first report from India.
Pai N; Shetty S; Idicula-Thomas S; Kulkarni B; Ghosh K
Thromb Haemost; 2009 Apr; 101(4):785-7. PubMed ID: 19350130
[No Abstract] [Full Text] [Related]
9. Novel mechanisms for activated protein C cytoprotective activities involving noncanonical activation of protease-activated receptor 3.
Burnier L; Mosnier LO
Blood; 2013 Aug; 122(5):807-16. PubMed ID: 23788139
[TBL] [Abstract][Full Text] [Related]
10. The cytoprotective protein C pathway.
Mosnier LO; Zlokovic BV; Griffin JH
Blood; 2007 Apr; 109(8):3161-72. PubMed ID: 17110453
[TBL] [Abstract][Full Text] [Related]
11. The protein C omega-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity.
Preston RJ; Morse C; Murden SL; Brady SK; O'Donnell JS; Mumford AD
Br J Haematol; 2009 Mar; 144(6):946-53. PubMed ID: 19133979
[TBL] [Abstract][Full Text] [Related]
12. Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand.
Bae JS; Rezaie AR
Thromb Haemost; 2008 Jul; 100(1):101-9. PubMed ID: 18612544
[TBL] [Abstract][Full Text] [Related]
13. Cell painting with an engineered EPCR to augment the protein C system.
Bouwens EA; Stavenuiter F; Mosnier LO
Thromb Haemost; 2015 Nov; 114(6):1144-55. PubMed ID: 26272345
[TBL] [Abstract][Full Text] [Related]
14. Occupancy of human EPCR by protein C induces β-arrestin-2 biased PAR1 signaling by both APC and thrombin.
Roy RV; Ardeshirylajimi A; Dinarvand P; Yang L; Rezaie AR
Blood; 2016 Oct; 128(14):1884-1893. PubMed ID: 27561318
[TBL] [Abstract][Full Text] [Related]
15. Protein C anticoagulant and cytoprotective pathways.
Griffin JH; Zlokovic BV; Mosnier LO
Int J Hematol; 2012 Apr; 95(4):333-45. PubMed ID: 22477541
[TBL] [Abstract][Full Text] [Related]
16. Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala-activated protein C mediated by factor Va.
Gale AJ; Sun X; Heeb MJ; Griffin JH
Protein Sci; 1997 Jan; 6(1):132-40. PubMed ID: 9007985
[TBL] [Abstract][Full Text] [Related]
17. Factor V and thrombotic disease: description of a janus-faced protein.
Nicolaes GA; Dahlbäck B
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):530-8. PubMed ID: 11950687
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of thrombin formation by active site mutated (S360A) activated protein C.
Nicolaes GA; Bock PE; Segers K; Wildhagen KC; Dahlbäck B; Rosing J
J Biol Chem; 2010 Jul; 285(30):22890-900. PubMed ID: 20484050
[TBL] [Abstract][Full Text] [Related]
19. Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition.
Dahlbäck B; Villoutreix BO
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1311-20. PubMed ID: 15860736
[TBL] [Abstract][Full Text] [Related]
20. The endothelial cell protein C receptor: cell surface conductor of cytoprotective coagulation factor signaling.
Gleeson EM; O'Donnell JS; Preston RJ
Cell Mol Life Sci; 2012 Mar; 69(5):717-26. PubMed ID: 21968919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
